Arterial stiffness in symptomatic smokers with normal lung function Source: ERJ Open Res, 3 (3) 00037-2017; 10.1183/23120541.00037-2017 Year: 2017
The relationship between pain and exercise capacity, peripheral muscle strength, and quality of life in individuals with pulmonary arterial hypertension Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease Year: 2017
Reduced pulmonary function is associated with aortic stiffness in men free of cardiovascular diseases Source: Eur Respir J 2002; 20: Suppl. 38, 516s Year: 2002
Longitudinal measurements of pulmonary function beginning in infancy – differences in children with and without increased airway responsiveness Source: Eur Respir J 2006; 28: Suppl. 50, 270s Year: 2006
Is COPD a risk factor for increased arterial stiffness? Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD Year: 2008
The relationship between lung function and blood pressure and the mediation role of physical activity and cardiorespiratory fitness in adults: cross-sectional results from the EPIMOV study Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018
Resistive and dynamic exercise stress testing in COPD and IPF candidates to lung transplantation: role of the pulmonary arterial stiffness Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Annual lung function changes in young patients with chronic lung disease Source: Eur Respir J 2002; 19: 886-891 Year: 2002
The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation Source: Eur Respir J 2014; 43: 1306-1315 Year: 2014
Increased arterial stiffness in adult patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Relationship between dyspnea, exercise performance, pulmonary functions, and peripheral muscle strength in patients with pulmonary hypertension Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010
Impaired pulmonary function and its association with clinical outcomes, exercise capacity and quality of life in children with congenital heart disease Source: Virtual Congress 2020 – Clinical year in review Year: 2020
Relationship between upper extremity functions and balance in individuals with pulmonary arterial hypertension Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease Year: 2017
Altered interaction of respiratory muscle activity, flow and lung volume in infants with chronic lung disease compared to healthy controls Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008
Increased arterial stiffness in children with cystic fibrosis Source: Eur Respir J 2012; 39: 1536-1537 Year: 2012
Correlation between the cross-sectional area of the lung area and pulmonary haemodynamics in chronic thromboembolic pulmonary hypertension Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020